Eli Lilly and Company's Fiscal Year is From January To December - All Figures are in USD.
The item "Cash-Flow-Per-Share" stands at 19.34 United States Dollars as of 09/30/2025, the highest value at least since 06/30/2022, the period currently displayed.
As of the end of Eli Lilly and Company's third quarter, the item "Cash Flow Per Share" stands at 19.34 USD. This represents an increase of 53.41 percent compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 177.08 percent compared to the value the year prior.
The 1 year change in percent is 177.08.
The 3 year change in percent is 113.09.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Johnson & Johnson - Cash Flow Per Share | 486,508,953,600.00 |
![]() | AbbVie Inc - Cash Flow Per Share | 399,570,305,024.00 |
![]() | Roche Holding AG - Cash Flow Per Share | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Cash Flow Per Share | 280,205,508,085.11 |
![]() | Novartis AG - Cash Flow Per Share | 255,096,620,580.91 |